Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-37606444

RESUMEN

TECHNICAL ABSTRACTBackground: Commercial drones are rapidly transforming business operations, however there is a paucity of research evaluating occupational hazards and risks associated with drone deployment in the workplace.Purpose: We aimed to identify challenges of human-drone collaborations and assess drone pilot perceptions of workplace safety.Methods: An online questionnaire was generated and sent to 308 drone pilots working in different industries. A total of 75 of responses were included for data analysis. Descriptive statistics, principal component analysis, and association rule mining were employed to extract knowledge from the obtained data.Results: Our results indicate that human factors are the main contributors to workplace drone mishaps. Poor communication, information display, and control modes were found to be chief obstacles to effective human-drone collaboration. Drone pilots indicated a propensity for complying with and participating in safety practices. Following safety procedures, receiving technical training, and flying outdoors may all be associated with a lower risk of drone mishaps.Conclusions: Offering professional training to pilots and following safety procedures could decrease the risks associated with occupational drones.


A long-standing debate has surrounded the factors that lead to drone mishaps. The results of our study indicate that, from the perspective of drone pilots, situational awareness, decision-based, and skill-based errors are the primary human-factors relevant causes of drone mishaps. Additionally, deficiencies in drone interfaces should be addressed comprehensively to ensure humans can more precisely control drones. Our findings suggest that following safety procedures, receiving technical training, and flying outdoors were associated with a reduced risk of drone-related mishaps at work.

2.
Iran J Allergy Asthma Immunol ; 20(5): 537-549, 2021 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-34664813

RESUMEN

Nosocomial infections caused by Acinetobacter baumannii (A. baumannii) nosocomial infections caused by Acinetobacter baumannii (A. baumannii) are considered as a global serious problem in hospitalized patients because of emerging antibiotic resistance. Immunotherapy approaches are promising to prevent such infections. In our previous study, five antigenic epitopes of outer membrane protein A (OmpA), as the most dangerous virulence molecule in A. baumanii, were predicted in silico. In this study, the investigators evaluated some immunological aspects of the peptides. Five peptides were separately injected into C5BL/6 mice; then the cytokine production (interleukin-4 and interferon-gamma) of splenocytes and opsonophagocytic activity of immunized serum were assessed. To identify the protective function of the peptides, animal models of sepsis and pneumonia infections were actively and passively immunized with selected peptides and pooled sera of immunized mice, respectively. Then, survival rates of them were compared with the non-infected controls. Based on the results, activated spleen cells in P127 peptide-immunized mice exhibited an increase level of IFN-γ compared with the other experimental groups, but not about the IL-4 concentration. The results of opsonophagocytic assay revealed an appropriate killing activity of produced antibodies against A. baumannii in a dose-dependent manner. Further, the survival rates of the mice under passive immunization with the immunized sera or active immunization with P127 peptide were significantly more than those in the control group. Moreover, the survival rate of the P127 peptide immunized group was considerably higher than that among the other peptide-immunized group. In conclusion, findings indicated that peptides derived from outer membrane protein-A can be used as a promising tool for designing the epitope-based vaccines against infections caused by A. baumannii.


Asunto(s)
Infecciones por Acinetobacter/prevención & control , Acinetobacter baumannii/inmunología , Proteínas de la Membrana Bacteriana Externa/inmunología , Vacunas Bacterianas/inmunología , Epítopos/inmunología , Neumonía Bacteriana/prevención & control , Sepsis/prevención & control , Infecciones por Acinetobacter/inmunología , Infecciones por Acinetobacter/mortalidad , Animales , Antígenos Bacterianos/inmunología , Vacunas Bacterianas/administración & dosificación , Citocinas/metabolismo , Modelos Animales de Enfermedad , Interacciones Huésped-Patógeno/inmunología , Inmunización , Ratones , Neumonía Bacteriana/inmunología , Neumonía Bacteriana/mortalidad , Pronóstico , Sepsis/inmunología , Sepsis/mortalidad , Resultado del Tratamiento
3.
Iran J Allergy Asthma Immunol ; 19(6): 647-659, 2020 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-33463134

RESUMEN

The presence of ambient particulate matter (PM) poses more dangers to human health than that of other common air pollutants such as Carbon dioxide (Co2) and ozone.  Epidemiologic studies show a direct correlation between PM and the risk of respiratory and cardiovascular diseases. The immune system seems to play a critical role in the process of these diseases. The main goal of this study was to investigate the effect of Tehran particulate matter in two aerodynamic diameters (PM2.5 and PM10) on alveolar macrophages (AM) from C57/BL6 mice. To evaluate the inflammatory effects of PMs, cultured alveolar, and peritoneal macrophages were treated with PM2.5 and PM10 (concentrations of 5 µg/mL and 10 µg/mL). Tumor necrosis factor-alpha (TNF-α) and IL-10 (representatives of inflammatory and anti-inflammatory cytokines, respectively) were assessed in the culture supernatant by ELISA. Expression of arginase and inducible nitric oxide synthase (iNOS) genes was carried out by quantitative real-time PCR. Different functional types of cultured alveolar macrophages (M1, M2) were also determined in this study. Our results suggest that PM2.5 induces M1 inflammatory phenotype in comparison with PM10. We found Also, an increase in TNF-α and M1-related gene expression (iNOS), as well as a decrease in both IL-10 and M2 phenotype genes (Arginase). Moreover, a reduction in phagocytic capacity and increased apoptosis function of macrophage cells were detected. PM2.5 as a major component in hydrocarbons has a considerable effect on polarizing the alveolar macrophages to an inflammatory phenotype and eliciting lung inflammation in mice.


Asunto(s)
Macrófagos Alveolares/efectos de los fármacos , Macrófagos Peritoneales/efectos de los fármacos , Material Particulado/farmacología , Contaminantes Atmosféricos/farmacología , Animales , Apoptosis/efectos de los fármacos , Arginasa/metabolismo , Citocinas/metabolismo , Expresión Génica/efectos de los fármacos , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Interleucina-10/metabolismo , Macrófagos Alveolares/metabolismo , Macrófagos Peritoneales/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fagocitos/efectos de los fármacos , Fagocitos/metabolismo , Fenotipo , Factor de Necrosis Tumoral alfa/metabolismo
4.
Acta Dermatovenerol Croat ; 20(4): 267-71, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23317490

RESUMEN

Epidermodysplasia verruciformis is a rare genodermatosis characterized by inherited susceptibility to infection with certain papillomaviruses, which leads to the development of disseminated plane wart-like lesions. In some patients, lesions resembling pityriasis versicolor appear. Epidermodysplasia verruciformis has also been reported in immunosuppressed patients, most notably those with HIV infection. The affected patients are predisposed to development of skin and mucosal malignancies. We describe the rare occurrence of plasmablastic lymphoma in a patient with long lasting epidermodysplasia verruciformis and hepatitis B virus infection.


Asunto(s)
Epidermodisplasia Verruciforme/epidemiología , Hepatitis B/epidemiología , Linfoma/epidemiología , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Comorbilidad , Ciclofosfamida/uso terapéutico , Doxorrubicina/uso terapéutico , Humanos , Linfoma/tratamiento farmacológico , Linfoma/patología , Masculino , Infecciones por Papillomavirus/epidemiología , Prednisolona/uso terapéutico , Vincristina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...